Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$361M |
| 2 |
CVS Health
CVS
|
+$180M |
| 3 |
Cigna
CI
|
+$158M |
| 4 |
Microsoft
MSFT
|
+$102M |
| 5 |
Amazon
AMZN
|
+$90M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$301M |
| 2 |
AET
Aetna Inc
AET
|
+$270M |
| 3 |
PX
Praxair Inc
PX
|
+$184M |
| 4 |
ANDV
Andeavor
ANDV
|
+$97.3M |
| 5 |
COL
Rockwell Collins
COL
|
+$89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.86% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 10.39% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACBI
2551
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $958K | ﹤0.01% |
58,466
+2,681
| +5% | +$44.1K |
|
2552
York Water
YORW
$502M
| $954K | ﹤0.01% |
29,732
+1,221
| +4% | +$39.2K |
|
|
RNET
2553
DELISTED
RigNet, Inc.
RNET
| $948K | ﹤0.01% |
74,951
-5,062
| -6% | -$84.3K |
|
2554
NVE Corp
NVEC
$562M
| $941K | ﹤0.01% |
10,749
+85
| +0.8% | +$7.7K |
|
|
SFE
2555
DELISTED
Safeguard Scientifics, Inc.
SFE
| $938K | ﹤0.01% |
108,805
+6,577
| +6% | +$57.4K |
|
|
OLBK
2556
DELISTED
Old Line Bancshares, Inc.
OLBK
| $934K | ﹤0.01% |
35,458
+1,300
| +4% | +$37.8K |
|
2557
Rush Enterprises Class B
RUSHB
$6.04B
| $931K | ﹤0.01% |
58,822
-585
| -1% | -$9.52K |
|
|
DSKE
2558
DELISTED
Daseke, Inc. Common Stock
DSKE
| $930K | ﹤0.01% |
252,713
-32,788
| -11% | -$176K |
|
2559
Sportsman's Warehouse
SPWH
$44.5M
| $922K | ﹤0.01% |
210,334
-2,084
| -1% | -$10.1K |
|
2560
Gogo Inc
GOGO
$565M
| $918K | ﹤0.01% |
306,936
-3,356
| -1% | -$16.8K |
|
2561
Donegal Group Class A
DGICA
$731M
| $915K | ﹤0.01% |
67,024
+9,013
| +16% | +$125K |
|
|
CORR
2562
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $915K | ﹤0.01% |
27,640
+1,803
| +7% | +$64.4K |
|
|
CSLT
2563
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $912K | ﹤0.01% |
419,846
+11,098
| +3% | +$27.5K |
|
2564
Liquidity Services
LQDT
$1.22B
| $911K | ﹤0.01% |
147,572
-1,858
| -1% | -$11.5K |
|
2565
United States Lime & Minerals
USLM
$3.16B
| $908K | ﹤0.01% |
63,940
+4,640
| +8% | +$69.2K |
|
|
TARO
2566
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $908K | ﹤0.01% |
10,717
+487
| +5% | +$46.9K |
|
|
INXN
2567
DELISTED
Interxion Holding N.V.
INXN
| $908K | ﹤0.01% |
16,758
-444
| -3% | -$26.7K |
|
2568
Hackett Group
HCKT
$270M
| $904K | ﹤0.01% |
56,421
+3,621
| +7% | +$67.5K |
|
|
CRCM
2569
DELISTED
CARE.COM, INC.
CRCM
| $900K | ﹤0.01% |
46,570
+1,570
| +3% | +$28.5K |
|
2570
Crawford & Co Class B
CRD.B
$491M
| $896K | ﹤0.01% |
99,505
+6,012
| +6% | +$54.6K |
|
2571
Foster
FSTR
$430M
| $896K | ﹤0.01% |
56,341
+1,622
| +3% | +$30.3K |
|
2572
Enphase Energy
ENPH
$4.96B
| $894K | ﹤0.01% |
188,850
| – | – |
|
2573
First Mid Bancshares
FMBH
$1.39B
| $893K | ﹤0.01% |
27,972
+700
| +3% | +$25.1K |
|
2574
Quanterix
QTRX
$164M
| $892K | ﹤0.01% |
48,666
-3,749
| -7% | -$67.3K |
|
|
AGNT
2575
AGNT Inc
AGNT
$666M
| $891K | ﹤0.01% |
251,690
-4,704
| -2% | -$26.4K |
|
Similar funds
Charles Schwab's Q4 2018 Portfolio in Review
As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
- Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
- Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
- Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
- Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
- Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
- Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.
Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.